The renin-angiotensin system in the human eye
The circulating renin-angiotensin system (RAS) plays an important role in the control of electrolyte homeostasis and blood pressure. The rate limiting step in the RAS system is the kidney derived enzyme renin, an aspartyl protease, which cleaves its substrate angiotensinogen, a liver derived circulating Oa2 globulin in plasma, to form the decapeptide angiotensin I. Angiotensin I is then converted by the angiotensin converting enzyme (ACE) to In the pathogenesis of glaucoma, angiotensin induced vascular tone has been implicated as a pathogenic mechanism in glaucomatous cupping and in damage to the optic nerve.27 28 Regulation of aqueous outflow, and hence intraocular pressure (IOP), occurs in or near the ciliary body and the iris. The evidence for the presence of RAS components necessary for the generation of angiotensin II in this region is suggestive of a local ocular RAS also involved in regulation of IOP. The finding that corneal application of renin inhibitors,29-3' and of an ACE inhibitor,32 lowers IOP supports such a function. Angiotensin II contracts isolated dog sphincter pupillae via synthesis of cyclo-oxygenase products by acting on specific receptors.'5 33 The published data do not distinguish whether activated RAS in the eye is a cause or an effect of the investigated eye diseases. Logically, treatment with enzyme inhibitors, possessing sufficient lipid solubility to cross the blood ocular barriers, seems indicated in prophylaxis or therapy. As 
